Filter
157
Filtered Results: 157
Text search:
omicron
Featured
Recommendations
28
New Publications
6
Language
Document type
Guidelines
57
Studies & Reports
32
Fact sheets
18
Strategic & Response Plan
14
Situation Updates
10
No document type
9
Training Material
7
Manuals
5
Infographics
3
Videos
2
Countries / Regions
Brazil
9
Global
8
Latin America and the Carribbean
8
Africa
5
Kenya
4
Mozambique
4
Ukraine
3
Syria
2
Philippines
2
Germany
2
Argentina
2
South Africa
2
Ethiopia
2
El Salvador
1
Turkey
1
Sierra Leone
1
Nigeria
1
Senegal
1
Burundi
1
Peru
1
Asia
1
Venezuela
1
Jordan
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Southern Africa
1
Lebanon
1
Eastern Europe
1
Moldova
1
Russia
1
Namibia
1
Egypt
1
Angola
1
Chad
1
South Sudan
1
Iraq
1
Liberia
1
India
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
54
Women & Child Health
8
Public Health
7
Key Resources
7
Clinical Guidelines
4
Capacity Building
3
Pharmacy & Technologies
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
88
Caregiver
8
Planetary Health
8
Refugee
6
Conflict
6
Health Financing Toolbox
4
Mental Health
3
TB
3
Global Health Education
3
Natural Hazards
2
Disability
2
Pharmacy
2
NCDs
2
Polio
1
AMR
1
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Update on SARS-CoV-2 variant of concern Omicron
recommended
Update 70, 10 Dec. 2021
If Omicron is less severe, why are people ending up in the hospital and dying from it? Is it true that everyone will eventually get Omicron? Why is it important to reduce transmission? WHO's Dr Maria Van Kerkhove explains in Science in 5.
WHO’s Science in 5 Episode #63 - Omicron variant
recommended
What do we know about Omicron variant so far? WHO's Dr Maria Van Kerkhove updates on the transmissibility, severity, symptoms and ways to protect yourself in Science in 5.
Strengthening surveillance for Variant of Concern (VOC) Omicron (B.1.1.529): technical brief and priority actions for member states World Health Organization Headquarters, 28 November 2021
Wearing a face mask can help reduce the spread of COVID-19 in the community by reducing the release of respiratory droplets from asymptomatic / pre-symptomatic individuals or those with mild non-specific symptoms. The use of face masks for this purpose may be adopted to reduce the societal impact as...
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat...
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of variants of conc...
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
recommended
Contact tracing for COVID-19 is the process of identifying, assessing, and managing people who have been exposed to someone who has been infected with the SARS-CoV-2 virus, while quarantine is the separation of contacts from other people after exposure to a probable or confirmed case of SARS-CoV-2 i...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-...
Weekly epidemiological update on COVID-19, 28 September 2022
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
Remdesivir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Poster, 4 Janaury 2022
